ExodusPoint Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$2.47M Buy
2023
Q4
Sell
2023
Q3
$1.67M Buy
2023
Q2
$1.54M Buy
2023
Q1
Sell
2022
Q4
$1.21M Buy
2022
Q3
$486K Buy
2021
Q2
Sell
2021
Q1
$351K Sell
2020
Q4
$613K Buy
2020
Q3
$316K Sell
2020
Q2
$1.09M Buy